Agenus Inc.

About Agenus Inc.

Agenus is a biotechnology company focused on harnessing the power of the immune system to develop innovative immunotherapies with curative intent for individuals living with cancer. Their vision is to expand the patient population benefiting from immuno-oncology through combination approaches involving antibody therapeutics, adoptive cell therapies, adjuvants, and vaccines.

Products & Services

Botensilimab:A next-generation CTLA-4 antibody designed to extend curative benefits of immunotherapy to cold tumors, expand clinical benefits in hot tumors like melanoma, and improve tolerability by reducing side effects.

Immuno-Oncology Therapeutics:A broad repertoire of clinical-stage antibody programs, adoptive cell therapies (via MiNK Therapeutics), adjuvants, and vaccines (via SaponiQx) to treat cancer.

Specialties

Immunotherapy Antibody Therapeutics Adoptive Cell Therapies Cancer Vaccines Adjuvants CTLA-4 Antibodies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 22000000 MR: - FA: 22 million FAN: 22000000	D: 2024-11-27 FD: 2024-11-27	1 investors
2	RT: Royalty Financing T: - FT: Royalty Financing	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2024-05-07 FD: 2024-05-07	1 investors

Debt Latest

2024-11-27

$22.0M

1 investor (Pro only)

Royalty Financing 2024-05-07

$75.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Garo H. Armen

Chairman and Chief Executive Officer

J

Jennifer Buell

President and CEO of MiNK Therapeutics, Chairman, Executive Council at Agenus

T

Tracy Mazza Clemente

Chief People Officer

A

Alfred Dadson

Chief Manufacturing Officer

C

Christine Klaskin

Vice President, Finance and Principal Financial and Accounting Officer

S

Steven O'Day

Chief Medical Officer

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

Agenus Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised